IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex Secures Second Quarter Sales Hike, Enjoys Currency Boost

6:43 AM MDT | August 3, 2011 | Alex Scott

Fine chemicals firm Cambrex has recorded Ebitda for the second quarter of the year up 9% to $12.1 million, on corresponding sales up 18% to $67.5 million. Excluding a 10.7% favorable impact of foreign exchange, reflecting a weaker U.S. dollar, sales increased 6.9%. The increase is primarily due to higher sales of certain larger custom manufacturing products and higher volumes of generic active pharmaceutical ingredients (API). These increases were partially offset by the timing of orders for certain products, lower custom development revenues and lower pricing...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa